Total Neoadjuvant Therapy (TNT) for Rectal Cancer

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Transrapid, Flugtaxis, Hyperloop – Warum es neuartige Verkehrstechnik so schwer hat 28 min · 22 Sep 2026 · Das Wissen | SWR

In The Lab: Who Dares To Dance With Destiny 29 min · 22 Sep 2026 · Dan Does Footy

Fletch, Vaughan & Hayley's Lil Bitta Pod - 22nd September 2026 6 min · 22 Sep 2026 · ZM's Fletch, Vaughan & Hayley

By Order of the Faithfuls: Celebs? Don’t Need Them! (The Traitors: New Blood Recap) 1h 0m · 22 Sep 2026 · Two Ts In A Pod with Teddi Mellencamp and Tamra Judge

NPR News: 09-21-2026 8PM EDT 4 min · 22 Sep 2026 · NPR News Now

Alistair Nicholson in the studio! - AFL Coaches Association Senior Coach of the Year award | AFLCA CEO (22.09.26) 11 min · 22 Sep 2026 · Whateley

Report any issue

Source

Recorded16 Nov 2023

Publisherfeeds.buzzsprout.com

Handlerec:1648208

Show notes

Emre Gorgun, MD, colorectal surgeon and Vice Chair of Colorectal Surgery at Cleveland Clinic, joins the Cancer Advances podcast to talk about his study from Digestive Disease Week (DDW) on predicting complete responses to total neoadjuvant therapy (TNT) in patients with locally advanced rectal cancer. Listen as Dr. Gorgun share insights on success rates of TNT, the factors influencing complete response, patient surveillance, and the potential use of immunotherapy.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in